Study Title: Phase II Trial of Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma: Big Ten Cancer Research Consortium BTCRC-HN17-111
 

• Open to Accrual at:
  • University of Illinois Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
  • University of Michigan Rogel Cancer Center
  • Masonic Cancer Center, University of Minnesota
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • University of Wisconsin Carbone Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT03942653
  • Big Ten CRC News Release
• Publications and Presentations
  • Publication: 2022 ASCO Annual Meeting 

Study Contact: studies@hoosiercancer.org; (317) 921-2050.